There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

The rollout will allow FDA scientists and subject-matter experts to spend less time on ‘tedious, repetitive tasks,’ the ...

If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...

the Food and Drug Administration is suggesting that AI will be a part of its operations sooner rather than later. The FDA announced an "aggressive timeline" to deploy artificial intelligence ...